Login

DBA Group Shares Its Story: Roundtable Discussion Hosted by DBA Group | Manuela Grattoni , President of DBA group spa 00:10:00

Share On Facebook Share On Twitter

Manuela Grattoni is Board Member at Piovan Spa.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Tharisa: Thriving as a Leading Low-Cost Producer of PGMs and Chrome in South Africa
00:10:00
"Interim CEO David Landerborn and CFO Ellen Solum address questions on Techstep's Q3 2023 financial results."
00:10:00
Revolutionizing Drug Discovery with AI: Accelerating Medicine Development through Innovative Biologics| Sean McClain, CEO, Absci Corp.
00:10:00
Fran Horowitz on Abercrombie & Fitch’s Remarkable Turnaround: Ten Quarters of Growth and Counting | Fran Horowitzr , CEO, Abercrombie & Fitch Co.
00:10:00
CEO Paul Goranson at 2024 Energy Transition Metals Summit in DC | Paul Goranson - CEO of enCore Energy Corp
00:10:00
Find Peace and Purpose with Tailored Financial Planning at Echo Collaborativ
00:10:00
Steven De Proost, CEO of 7C Solarparken, focuses on ambitious growth targets, strategic goals, and transparent directors' dealings.
00:10:00
Alumni Spotlight: Joe Hete '76 | JOE HETE - Chief Executive Officer of Air Transport Services Group Inc.
00:10:00
Modify IT Holdings' strategy of acquiring growth | TIFFANY DUNSDON, Chief Executive Officer, Adapt IT Holdings Ltd ADI:JNB
00:10:00
Probability of Making Money in the Stock Market | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
Boost Your Resume: Tips to Stand Out in Job Applications
00:10:00
Insights into Fortinova’s Journey to Nasdaq First North Premier | Anders Johansson, CEO, Fortinova Fastigheter AB.

© 2026 Nehu